Tiotropium bromide and Ticagrelor drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tiotropium bromide (tiotropium bromide) and Ticagrelor (ticagrelor). Common drug interactions include abdominal pain among females and rhabdomyolysis among males.

The phase IV clinical study analyzes what interactions people have when they take Tiotropium bromide and Ticagrelor. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Tiotropium bromide?

Tiotropium bromide has active ingredients of tiotropium bromide. eHealthMe is studying from 7,688 Tiotropium bromide users. Check the latest studies of Tiotropium bromide.

What is Ticagrelor?

Ticagrelor has active ingredients of ticagrelor. eHealthMe is studying from 8,499 Ticagrelor users. Check the latest studies of Ticagrelor.

On Jul, 10, 2026

24 people who take Tiotropium bromide and Ticagrelor together, and have interactions are studied.

Tiotropium bromide and Ticagrelor drug interactions.

What are the common drug interactions of Tiotropium Bromide and Ticagrelor, by gender? *:

female:

Abdominal pain
Adverse event
Blood alkaline phosphatase increased
Cystitis (inflammation of the wall of the bladder)
Hepatic steatosis (fatty liver disease)
Hospitalisation
Impaired healing
Lower respiratory tract infection
Malaise (a feeling of general discomfort or uneasiness)
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)

male:

Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
Cough
Congestive cardiomyopathy (weakening of heart muscle)
Ejection fraction decreased (systolic heart failure)
Gastritis erosive (a break in the surface layer of the membrane lining the stomach with infection)
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Haemoglobin decreased
Intra-abdominal haemorrhage (intra-abdominal bleeding)
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Pleural effusion (water on the lungs)

What are the common drug interactions of Tiotropium Bromide and Ticagrelor, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Abdominal pain
Adverse event
Blood alkaline phosphatase increased
Cystitis (inflammation of the wall of the bladder)
Hepatic steatosis (fatty liver disease)
Hospitalisation
Impaired healing
Lower respiratory tract infection
Malaise (a feeling of general discomfort or uneasiness)
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)

50-59:

Cardiac failure
Cardiomegaly (increased size of heart than normal)
Cerebral ischaemia (insufficient blood flow to the brain to meet metabolic demand)
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Congestive cardiomyopathy (weakening of heart muscle)
Ejection fraction decreased (systolic heart failure)
Intra-abdominal haemorrhage (intra-abdominal bleeding)
Pleural effusion (water on the lungs)
Pneumonia
Pulmonary congestion (congestion in the lungs)

60+:

Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
Cough
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Pyrexia (fever)
Rectal haemorrhage (bleeding from anus)
Dyspnoea (difficult or laboured respiration)
General physical health deterioration (weak health status)
Haematemesis (vomiting of blood)
Blood urine present
Gastritis erosive (a break in the surface layer of the membrane lining the stomach with infection)

What are the existing conditions these people have? *

High Blood Pressure: 5 people, 20.83%
High Blood Cholesterol: 4 people, 16.67%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 12.50%
Percutaneous Coronary Intervention: 3 people, 12.50%
Pain: 3 people, 12.50%
Diabetes: 3 people, 12.50%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 3 people, 12.50%
Cardiac Disorder: 3 people, 12.50%
Neuropathy Peripheral (surface nerve damage): 2 people, 8.33%
Asthma: 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Tiotropium bromide and Ticagrelor?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously